Treatment of hepatitis C: a decision that needs careful consideration.
Wright
T L
TL
D000998:Antiviral Agents / Q000627:therapeutic use*; D004279:DNA, Viral / Q000097:blood; D018450:Disease Progression; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D016174:Hepacivirus / Q000187:drug effects* / Q000235:genetics; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D012254:Ribavirin / Q000627:therapeutic use*; D012306:Risk
D000998:Antiviral Agents; D004279:DNA, Viral; D012254:Ribavirin; D007372:Interferons